[Inhibition of kinin liberation in long-term perfusion].
D000818:Animals; D007611:Aprotinin / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004562:Electrocardiography; D005112:Extracorporeal Circulation; D005260:Female; D006975:Hypertension, Portal / Q000209:etiology; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000187:drug effects; D007705:Kinins / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010106:Oxygenators; D010477:Perfusion / Q000009:adverse effects*; D012770:Shock, Cardiogenic / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D013997:Time Factors
D007705:Kinins; D007611:Aprotinin
Inhibition der Kininliberation bei lang dauernder Perfusion